Latest Breaking News On - Glucocerebrosidase gcase - Page 1 : comparemela.com

GAIN THERAPEUTICS : REPORTS second QUARTER 2022 FINANCIAL RESULTS AND BUSINESS UPDATE - Form 8-K

GAIN THERAPEUTICS, INC. REPORTS second QUARTER 2022 FINANCIAL RESULTS AND BUSINESS UPDATE Presented Additional Supportive Preclinical Data for. | August 8, 2022

Glucocerebrosidase gcaseStacey jurchinsonEric richmanEuropean union horizonMovement society disorderGain therapeutics incExchange commission onWorld congress on parkinson diseaseZentalis pharmaceuticalsCompany annual report on formSilverstein foundation for parkinsonInternational parkinsonMichaelj fox foundation for parkinson researchAdditional supportive preclinical dataLead candidateFurther validating therapeutic potential

Gain Therapeutics, Inc Reports Second Quarter 2022 Financial Results and Business Update

Gain Therapeutics, Inc Reports Second Quarter 2022 Financial Results and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Glucocerebrosidase gcaseStacey jurchisonEric richmanEuropean union horizonMovement society disorderGain therapeutics incExchange commission onWorld congress on parkinson diseaseZentalis pharmaceuticalsCompany annual report on formSilverstein foundation for parkinsonInternational parkinsonMichaelj fox foundation for parkinson researchWall streetChief executive officerRelated disorders

Gain Therapeutics Presents Positive Preclinical Data On Its Gaucher Disease Program at IWGGD Symposium

Gain Therapeutics Presents Positive Preclinical Data On Its Gaucher Disease Program at IWGGD Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Gaucher diseasegaucherGlucocerebrosidase gcaseEric richmanEuropean union horizonSilverstein foundation for parkinsonGain therapeutics incMichaelj fox foundation for parkinson researchShow promising pharmacological activityGain therapeuticsInc gain therapeuticsSilverstein foundationMedia contactsPahlaviargot partners

Gain Therapeutics (GANX) Reports Positive Preclinical Data On Its Gaucher Disease Program

Gain Therapeutics (GANX) Reports Positive Preclinical Data On Its Gaucher Disease Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Glucocerebrosidase gcaseEric richmanGain therapeutics incWall streetShow promising pharmacological activityGain therapeutics

Gain Therapeutics Presents Positive Preclinical Data On Its

Lead compound GT-02329 increases GCase levels and activity, depletes toxic substrates glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph) in.

Glucocerebrosidase gcaseEric richmanEuropean union horizonSilverstein foundation for parkinsonGain therapeutics incMichaelj fox foundation for parkinson researchShow promising pharmacological activityGain therapeuticsSilverstein foundationMedia contactsNasdaq ganxGain therapeutics